Paper40539208
Evaluation of Kallistatin Levels in COPD Exacerbations.
Akgün KB and 2 others. Can Respir J, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Evaluation of Kallistatin Levels in COPD Exacerbations. Papers, record 40539208. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40539208
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pulmonary Disease, Chronic Obstructive | Major topic |
| Serpins | Major topic |
| Humans | |
| Male | |
| Female | |
| Middle Aged | |
| Aged | |
| Vascular Endothelial Growth Factor A | |
| Biomarkers | |
| Case-Control Studies | |
| Tumor Necrosis Factor-alpha |
Source PubMed
References17
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30306206 | A review of inflammatory mechanism in airway diseases. | Inflamm Res | 2019 | https://conductscience.org/library/papers/30306206 | PubMed |
| 2 | 35624831 | Oxidative Stress in Chronic Obstructive Pulmonary Disease. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/35624831 | PubMed |
| 3 | 26579446 | Kallistatin, a new and reliable biomarker for the diagnosis of liver cirrhosis. | Acta Pharm Sin B | 2015 | https://conductscience.org/library/papers/26579446 | PubMed |
| 4 | 30622668 | Protective Role of Endogenous Kallistatin in Vascular Injury and Senescence by Inhibiting Oxidative Stress and Inflammation. | Oxid Med Cell Longev | 2018 | https://conductscience.org/library/papers/30622668 | PubMed |
| 5 | 28742513 | Kallistatin: double-edged role in angiogenesis, apoptosis and oxidative stress. | Biol Chem | 2017 | https://conductscience.org/library/papers/28742513 | PubMed |
| 6 | 22015083 | Pulmonary function, oxidative stress and inflammatory markers in severe COPD exacerbation. | Respir Med | 2011 | https://conductscience.org/library/papers/22015083 | PubMed |
| 7 | 31390957 | Association between tumor necrosis factor-α and chronic obstructive pulmonary disease: a systematic review and meta-analysis. | Ther Adv Respir Dis | 2019 | https://conductscience.org/library/papers/31390957 | PubMed |
| 8 | 20504760 | Serum levels of VEGF and bFGF in hypoxic patients with exacerbated COPD. | Eur Cytokine Netw | 2010 | https://conductscience.org/library/papers/20504760 | PubMed |
| 9 | 39170822 | Early detection and prediction of acute exacerbation of chronic obstructive pulmonary disease. | Chin Med J Pulm Crit Care Med | 2023 | https://conductscience.org/library/papers/39170822 | PubMed |
| 10 | 27432868 | Protective Role of Kallistatin in Vascular and Organ Injury. | Hypertension | 2016 | https://conductscience.org/library/papers/27432868 | PubMed |
| 11 | 23394256 | Plasma kallistatin levels in patients with severe community-acquired pneumonia. | Crit Care | 2013 | https://conductscience.org/library/papers/23394256 | PubMed |
| 12 | 31371032 | Comparison of oxidant/antioxidant balance in COPD and non-COPD smokers. | Heart Lung | 2019 | https://conductscience.org/library/papers/31371032 | PubMed |
| 13 | 26870880 | The relationships among the levels of oxidative and antioxidative parameters, FEV1 and prolidase activity in COPD. | Redox Rep | 2017 | https://conductscience.org/library/papers/26870880 | PubMed |
| 14 | 30286402 | Lower serum kallistatin level is associated with 28-day mortality in patients with septic shock. | J Crit Care | 2018 | https://conductscience.org/library/papers/30286402 | PubMed |
| 15 | 28542440 | Plasma kallistatin in critically ill patients with severe sepsis and septic shock. | PLoS One | 2017 | https://conductscience.org/library/papers/28542440 | PubMed |
| 16 | 37351609 | Systemic Markers of Lung Function and Forced Expiratory Volume in 1 Second Decline across Diverse Cohorts. | Ann Am Thorac Soc | 2023 | https://conductscience.org/library/papers/37351609 | PubMed |
| 17 | 28386328 | Kallistatin protects against bleomycin-induced idiopathic pulmonary fibrosis by inhibiting angiogenesis and inflammation. | Am J Transl Res | 2017 | https://conductscience.org/library/papers/28386328 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42939691 | α-Lipoic Acid, with or Without Ambrisentan, Attenuates Experimental Pulmonary Arterial Hypertension: Associations with AMPK/mTOR/NF-κB Signaling and Kallistatin. | Biomolecules | 2026 | https://conductscience.org/library/papers/42939691 | PubMed |
| 41918726 | The role of programmed cell death in chronic obstructive pulmonary disease: from pathogenesis to treatment. | Front Immunol | 2026 | https://conductscience.org/library/papers/41918726 | PubMed |
| 41561118 | The multifaceted role of kallistatin in human diseases: mechanistic insights and translational potential. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/41561118 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| SERPINA4 | 5267 | PubTator's text mining | https://conductscience.org/library/genes/5267 | NCBI Gene |
| THAS | 7055 | PubTator's text mining | https://conductscience.org/library/genes/7055 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40539208
GET https://conductscience.org/api/papers/v1/40539208/authors